This trial looks to see if a new way to treat chronic psychotic disorders, called Pharmacologic Augmentation of Cognitive Therapy (PACT), is more effective than the current standard treatment.
- Schizoaffective Disorder
1 Primary · 0 Secondary · Reporting Duration: screening session (week 1) followed by weekly sessions for 10 weeks, 3 times per week (weeks 2- ~12), and 2 post session tests after week 12 and after week 22
2 Treatment Groups
TCT + AMPH
1 of 2
TCT + PBO
1 of 2
70 Total Participants · 2 Treatment Groups
Primary Treatment: TCT + AMPH · Has Placebo Group · Phase 2
Who is running the clinical trial?
Age 18 - 55 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many research participants are engaging with this investigation?
"Affirmative. Records hosted on clinicaltrials.gov suggest that this research initiative, posted initialy in November 2020, is presently seeking volunteers. Approximately 70 people must be enlisted from a single medical facility." - Anonymous Online Contributor
Are there any specific criteria for potential participants of this clinical research?
"To be eligible to partake in the trial, applicants must have schizophrenia and fall between 18-55 years of age. The study is attempting to recruit a total of 70 individuals." - Anonymous Online Contributor
What can be said regarding the safety of TCT + AMPH treatments for patients?
"The current level of safety data surrounding TCT + AMPH has earned it a score of 2. This is because the trial currently in progress is only Phase 2, demonstrating some evidence for its security but not yet its efficacy." - Anonymous Online Contributor
Do the parameters of this trial include individuals over forty years old?
"This investigation is only open to participants aged 18-55. However, there are 94 studies specifically aimed at those below the age of consent and 210 for seniors over 65 years old." - Anonymous Online Contributor
Is enrollment still open for this research trial?
"Yes, according to clinicaltrials.gov, this medical trial is actively seeking participants. Initially shared on November 9th 2020 and most recently updated on June 2nd 2022, the study expects to recruit 70 individuals from a single site." - Anonymous Online Contributor